Vikas V. Dukhande

889 total citations
41 papers, 615 citations indexed

About

Vikas V. Dukhande is a scholar working on Molecular Biology, Rheumatology and Cancer Research. According to data from OpenAlex, Vikas V. Dukhande has authored 41 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 11 papers in Rheumatology and 8 papers in Cancer Research. Recurrent topics in Vikas V. Dukhande's work include Glycogen Storage Diseases and Myoclonus (11 papers), Ubiquitin and proteasome pathways (7 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Vikas V. Dukhande is often cited by papers focused on Glycogen Storage Diseases and Myoclonus (11 papers), Ubiquitin and proteasome pathways (7 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Vikas V. Dukhande collaborates with scholars based in United States, Spain and China. Vikas V. Dukhande's co-authors include Ketan Patel, Aishwarya Saraswat, James C. K. Lai, Yige Fu, Hari Priya Vemana, Matthew S. Gentry, Manali Patki, Christopher K. Daniels, Gauri H. Malthankar‐Phatak and Alfred Orina Isaac and has published in prestigious journals such as PLoS ONE, Molecular and Cellular Biology and Cell Metabolism.

In The Last Decade

Vikas V. Dukhande

37 papers receiving 606 citations

Peers

Vikas V. Dukhande

ONCOL

RHEUM

BIOMA

Qing Wu China

Shuang Ding China

Hirofumi Yamauchi Japan

Bert Grobben Belgium

Tomoyuki Hisa Japan

Weixian Min Canada

Anindya Dey United States

Xiaoqian Liu China

Suvajit Sen United States

Silke Erdmann Germany

Qing Wu China

Vikas V. Dukhande

456 ×1.2

75 ×0.5

ONCOL

44 ×0.7

RHEUM

83 ×1.4

59 ×1.0

BIOMA

Citations per year, relative to Vikas V. Dukhande Vikas V. Dukhande (= 1×) peers Qing Wu

Countries citing papers authored by Vikas V. Dukhande

Since Specialization

Citations

This map shows the geographic impact of Vikas V. Dukhande's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikas V. Dukhande with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikas V. Dukhande more than expected).

Fields of papers citing papers by Vikas V. Dukhande

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vikas V. Dukhande. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikas V. Dukhande. The network helps show where Vikas V. Dukhande may publish in the future.

Co-authorship network of co-authors of Vikas V. Dukhande

This figure shows the co-authorship network connecting the top 25 collaborators of Vikas V. Dukhande. A scholar is included among the top collaborators of Vikas V. Dukhande based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vikas V. Dukhande. Vikas V. Dukhande is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yadav, Anjali, et al.. (2025). Permeability enhancer incorporated oral nanosuspension of ARV-825 PROTAC for Glioblastoma treatment. Journal of Pharmaceutical Investigation. 1 indexed citations

Dukhande, Vikas V., et al.. (2025). Palmitate-induced downregulation of lipocalin prostaglandin D2 synthase accompanies hepatic lipid accumulation in HepG2 cells. Molecular and Cellular Endocrinology. 608. 112615–112615.

Patel, Ketan, et al.. (2024). Synergistic Efficacy of CDK4/6 Inhibitor Abemaciclib and HDAC Inhibitor Panobinostat in Pancreatic Cancer Cells. Cancers. 16(15). 2713–2713. 4 indexed citations

Vemana, Hari Priya & Vikas V. Dukhande. (2022). Recent Advances in The Application of Nanomedicine for The Treatment of Diabetes. Nanomedicine. 17(2). 65–69. 2 indexed citations

Vemana, Hari Priya, et al.. (2022). Repurposing an Antiepileptic Drug for the Treatment of Glioblastoma. Pharmaceutical Research. 39(11). 2871–2883. 8 indexed citations

Vemana, Hari Priya, et al.. (2022). Metabolic alterations and mitochondrial dysfunction underlie hepatocellular carcinoma cell death induced by a glycogen metabolic inhibitor. Biochemical Pharmacology. 203. 115201–115201. 10 indexed citations

Saraswat, Aishwarya, Hari Priya Vemana, Vikas V. Dukhande, & Ketan Patel. (2022). Galactose-decorated liver tumor-specific nanoliposomes incorporating selective BRD4-targeted PROTAC for hepatocellular carcinoma therapy. Heliyon. 8(1). e08702–e08702. 51 indexed citations

Fu, Yige, et al.. (2021). Development of Dual ARV-825 and Nintedanib-Loaded PEGylated Nano-Liposomes for Synergistic Efficacy in Vemurafnib-Resistant Melanoma. Pharmaceutics. 13(7). 1005–1005. 45 indexed citations

Vemana, Hari Priya, et al.. (2021). A Novel Gene Therapy for Neurodegenerative Lafora Disease Via Epm2A -Loaded Dlindma Lipoplexes. Nanomedicine. 16(13). 1081–1095. 14 indexed citations

10.

Patki, Manali, et al.. (2021). In vitro assessment of a synergistic combination of gemcitabine and zebularine in pancreatic cancer cells. Experimental Cell Research. 405(2). 112660–112660. 15 indexed citations

11.

Kanabar, Dipti, et al.. (2020). Optimizing the aryl-triazole of cjoc42 for enhanced gankyrin binding and anti-cancer activity. Bioorganic & Medicinal Chemistry Letters. 30(17). 127372–127372. 9 indexed citations

12.

Fu, Yige, et al.. (2019). EphA2-Receptor Targeted PEGylated Nanoliposomes for the Treatment of BRAFV600E Mutated Parent- and Vemurafenib-Resistant Melanoma. Pharmaceutics. 11(10). 504–504. 27 indexed citations

13.

Kanabar, Dipti, et al.. (2019). Structural modification of the aryl sulfonate ester of cjoc42 for enhanced gankyrin binding and anti-cancer activity. Bioorganic & Medicinal Chemistry Letters. 30(4). 126889–126889. 21 indexed citations

14.

Dukhande, Vikas V., et al.. (2019). Inhibition of glycogen catabolism induces intrinsic apoptosis and augments multikinase inhibitors in hepatocellular carcinoma cells. Experimental Cell Research. 381(2). 288–300. 21 indexed citations

15.

Dukhande, Vikas V., et al.. (2011). Chronic hypoxia-induced alterations of key enzymes of glucose oxidative metabolism in developing mouse liver are mTOR dependent. Molecular and Cellular Biochemistry. 357(1-2). 189–197. 13 indexed citations

16.

Bhushan, Alok, et al.. (2009). Cytotoxicity of Metallic Oxide Nanoparticles in Human Neural and Non-Neural Cells. TechConnect Briefs. 2(2009). 135–138. 2 indexed citations

17.

Bhushan, Alok, et al.. (2008). Silicon Dioxide Nanoparticles Exert Dissimilar Cytotoxic Effects on Mammalian Cell Types. TechConnect Briefs. 2(2008). 126–129. 2 indexed citations

18.

Bhushan, Alok, Christopher K. Daniels, Vikas V. Dukhande, et al.. (2008). Differential Cytotoxicity of Metallic Oxide Nanoparticles in Mammalian Cells. TechConnect Briefs. 2(2008). 130–133. 4 indexed citations

19.

Dukhande, Vikas V., et al.. (2008). A Co-Culture Model for Nanotoxicity and Tissue Engineering Studies. TechConnect Briefs. 2(2008). 164–167.

20.

Bhushan, Alok, et al.. (2007). Silicon Dioxide Nanoparticles Can Exert Cytotoxic Effects on Neural Cells. TechConnect Briefs. 2(2007). 741–743. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact